Urology Center of Englewood

Latest Clinical News

FDA grants accelerated approval to erdafitinib for metastatic urothelial carcinoma (04-16-2019)
granted accelerated approval to Balversa (erdafitinib) for patients with locally advanced or metastatic urothelial carcinoma, with susceptible FGFR3 or FGFR2 genetic alterations, that has progressed during... Continue Reading

Darolutamide Delays Prostate Cancer Progression in Men with Resistant Prostate Cancer (03-14-2019)
Results of the phase III ARAMIS clinical trial were published in The New England Journal of Medicine and demonstrated that Darolutamide plus androgen deprivation therapy (ADT) significantly extends metastasis-free... Continue Reading

Adjuvant Taxotere Doesn’t Improve Outcomes in Early Stage High Risk Prostate Cancer (02-11-2019)
Patients with high-risk, non-metastatic prostate cancer saw no survival advantage and no delay in metastases with the addition of adjuvant docetaxel to androgen deprivation therapy (ADT), according to... Continue Reading

More News

Locations

Englewood
300 Grand Avenue, Suite 202
Englewood, NJ 07631
Phone: (201) 816-1900
Fax: (201) 816-1777
Click here for map

 

Cliffside Park
663 Palisade Ave. Suite 304
Cliffside Park, NJ 97010
Phone: (201) 313-1933
Fax: (201) 313-9599
Click here for map

 

Hospital Affiliations
Englewood Hospital Medical Center
Holy Name Hospital
Palisades Medical Center
Mt. Sinai Hospital (NYC)
Columbia – New York-Presbyterian